On 18-22 May, the International Diabetes Federation Technology and AI Working Group, represented by Chair Dr Amit Kumar Dey and Advisor Dr Banshi Saboo, was part of the IDF delegation at the 79th World Health Assembly (WHA79) in Geneva, contributing perspectives on responsible AI, digital health, diabetes care, health workforce readiness and equitable access to innovation.
During WHA79, the Working Group released the Geneva Review on Responsible AI in Diabetes Care as part of its ongoing efforts to advance global dialogue on safe, ethical and equitable AI in diabetes.
The Review reflects the need for coordinated action as AI-enabled tools expand rapidly across diabetes care. It highlights priority areas including data quality, representation bias, external validation, explainability, privacy, regulatory alignment, human oversight, adverse-event reporting, clinical outcome standards and equitable access.
The release marks an important step in the Working Group’s pathway from consultation and landscape mapping toward structured prioritisation, consensus-building and practical guidance. It also reinforces the need for global collaboration across clinicians, researchers, regulators, lived experience representatives, policymakers and technology developers.
Download the Geneva Review
